Astex Pharmaceuticals Announces December 14th Analyst and Investor Day Agenda
DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the agenda for its Analyst and Investor Day webcast, to take place from 10 am to 12:15 pm GMT on Friday, December 14th in London, UK.
Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
10:00 (5 min.)
Welcome and Introductions
Timothy L. Enns
SVP, Corporate Communications and Marketing
10:05 (10 min.)
Corporate Overview
James S.J. Manuso, PhD, MBA
Chairman and Chief Executive Officer
10:15 (20 min.)
Clinical Update
Mohammad Azab, MD, M Sc, MBA
Chief Medical Officer
10:35 (25 min.)
AT13387 & Prostate Cancer
Johann de Bono, MD, PhD
Royal Marsden Hospital
Institute of Cancer Research (ICR)
11:00 (25 min.)
SGI-110 & Ovarian Cancer
Robert Brown, PhD
Imperial College London
Institute of Cancer Research (ICR)
11:25 (20 min.)
Research & Discovery
Harren Jhoti, PhD
President and Director
11:45 (15 min.)
Partnering & Corporate Development
Martin Buckland, DPhil, MBA
Chief Business Officer
12:00 (10 min.)
Financial Overview
Michael Molkentin, CPA
Chief Financial Officer and Corporate Secretary
12:10 (5 min.)
Closing Remarks
James S.J. Manuso, PhD, MBA
Chairman and Chief Executive Officer
The times listed above are approximate and are subject to change.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273
CONTACT: Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel: +1 (925) 560-2810
E-mail: tim.enns@astx.com
Susanna Chau
Astex Pharmaceuticals, Inc.
Manager
Investor Relations
Tel: +1 (925) 560-2845
E-mail: susanna.chau@astx.com
Alan Roemer
The Trout Group
Managing Director
Tel: +1 (646) 378-2945
E-mail: aroemer@troutgroup.com
Kari Watson
MacDougall Biomedical Communications
Senior Vice President
Tel: +1 (781) 235-3060
E-mail: kwatson@macbiocom.com
Press Release $ASTX Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the agenda for its Analyst and Investor Day webcast, to take place from 10 am to 12:15 pm GMT on Friday, December 14th in London, UK.
Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
The times listed above are approximate and are subject to change.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273
CONTACT: Timothy L. Enns Astex Pharmaceuticals, Inc. Senior Vice President Corporate Communications & Marketing Tel: +1 (925) 560-2810 E-mail: tim.enns@astx.com Susanna Chau Astex Pharmaceuticals, Inc. Manager Investor Relations Tel: +1 (925) 560-2845 E-mail: susanna.chau@astx.com Alan Roemer The Trout Group Managing Director Tel: +1 (646) 378-2945 E-mail: aroemer@troutgroup.com Kari Watson MacDougall Biomedical Communications Senior Vice President Tel: +1 (781) 235-3060 E-mail: kwatson@macbiocom.com
Source: Astex Pharmaceuticals, Inc.